Clinical Experience with Specific COX-2 Inhibitors in Arthritis
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1725-1736
Author(s):
Leslie J. Crofford
COX-2 and the Kidneys
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1737-1753
Author(s):
D. O. Stichtenoth and J. C. Frolich
Regulation of Vascular Endothelial Nitric Oxide Production by Fatty Acids
Journal:
Current Organic Chemistry
Volume:
4
Page:
1111-1123
Author(s):
David S. Calnek and C. Michael Hart
Oligonucleotide-based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs
Journal:
Current Drug Targets
Volume:
1
Page:
15-23
Author(s):
Ryuichi Morishita, Motokuni Aoki and Yasufumi Keneda
Turnover Studies on Cardiac Natriuretic Peptides: Methodological,Pathophysiological and Therapeutical Considerations.
Journal:
Current Drug Metabolism
Volume:
1
Page:
85-105
Author(s):
Aldo Clerico, Giorgio Iervasi and Alessandro Pilo
Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
11-31
Author(s):
W. Jelkmann
The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
73-82
Author(s):
Domenico Ribatti, Angelo Vacca, Luisa Roncali and Franco Dammacco
Structure-activity Relationship of Chemical Penetration Enhan-cers in Transdermal Drug Delivery
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
593-608
Author(s):
N. Kanikkannan, K. Kandimalla, S. S. Lamba and M. Singh
New Trends in Thromboxane and Prostacyclin Modulators
Journal:
Current Medicinal Chemistry
Volume:
7
Page:
609-628
Author(s):
Jean -Michel Dogne, Xavier de Leval, Jacques Delarge, Jean -Louis David and Bernard initial Masereel
Withdrawal Notice: Atrial Fibrillation and Hypertension: “Quo Vadis”
Journal:
Current Hypertension Reviews
Volume:
15
Page:
1-1
Author(s):
McCall Walker, Paras Patel, Osung Kwon, Ryan J Koene, Daniel A. Duprez and Younghoon Kwon*